180 related articles for article (PubMed ID: 16450814)
21. Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction: A meta-analysis of randomized controlled trials.
Xu Y; Qiu Z; Yang R; Wu Y; Cheng X
Medicine (Baltimore); 2018 Dec; 97(51):e13690. PubMed ID: 30572494
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
23. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
24. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
Vantrimpont P; Rouleau JL; Wun CC; Ciampi A; Klein M; Sussex B; Arnold JM; Moyé L; Pfeffer M
J Am Coll Cardiol; 1997 Feb; 29(2):229-36. PubMed ID: 9014971
[TBL] [Abstract][Full Text] [Related]
25. Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects.
Held P
Am J Cardiol; 1993 Mar; 71(9):39C-44C. PubMed ID: 8096674
[TBL] [Abstract][Full Text] [Related]
26. Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.
Düngen HD; Kober L; Nodari S; Schou M; Otto C; Becka M; Kanefendt F; Winkelmann BR; Gislason G; Richard F; Nielsen OW; Gheorghiade M; Senni M
Clin Pharmacol Drug Dev; 2019 Oct; 8(7):942-951. PubMed ID: 30452784
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
Kochs M; Eggeling T; Hombach V
Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
[TBL] [Abstract][Full Text] [Related]
28. Myocardial infarction: when and how should we initiate treatment with ACE inhibitors? GISSI-3 Investigators.
Latini R; Maggioni AP; Zuanetti G
Cardiology; 1996; 87 Suppl 1():16-22. PubMed ID: 8681316
[TBL] [Abstract][Full Text] [Related]
29. Remodeling after myocardial infarction: an opportunity for early intervention.
Amos DJ; White HD
Basic Res Cardiol; 1997 Apr; 92(2):69-71. PubMed ID: 9166982
[No Abstract] [Full Text] [Related]
30. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction.
Fonarow GC
Cardiol Clin; 2008 Feb; 26(1):79-89, vii. PubMed ID: 18312908
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Moss AJ; Zareba W; Hall WJ; Klein H; Wilber DJ; Cannom DS; Daubert JP; Higgins SL; Brown MW; Andrews ML;
N Engl J Med; 2002 Mar; 346(12):877-83. PubMed ID: 11907286
[TBL] [Abstract][Full Text] [Related]
32. Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure.
Genovesi Ebert A; Colivicchi F; Malvezzi Caracciolo M; Riccio C
Monaldi Arch Chest Dis; 2009 Mar; 72(1):18-22. PubMed ID: 19645208
[TBL] [Abstract][Full Text] [Related]
33. Very early administration of ACE-inhibitors in acute myocardial infarction.
Maggioni AP; Geraci E
Int J Cardiol; 1998 May; 65 Suppl 1():S61-4. PubMed ID: 9706829
[TBL] [Abstract][Full Text] [Related]
34. [Treatment after myocardial infarction].
Beurrier D; Danchin N
Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
[TBL] [Abstract][Full Text] [Related]
35. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
[No Abstract] [Full Text] [Related]
36. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
37. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
Bauersachs J; Ertl G
Med Klin (Munich); 2006 Jun; 101(6):458-66. PubMed ID: 16767569
[TBL] [Abstract][Full Text] [Related]
38. Post-Myocardial Infarction Heart Failure.
Bahit MC; Kochar A; Granger CB
JACC Heart Fail; 2018 Mar; 6(3):179-186. PubMed ID: 29496021
[TBL] [Abstract][Full Text] [Related]
39. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
Arós Borau F; Loma-Osorio A; Torres Bosco A
Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
[TBL] [Abstract][Full Text] [Related]
40. Angiotensine converting enzyme inhibitors In acute myocardial infarction--a review.
Sawhney JP
Indian Heart J; 2011; 63(1):71-8. PubMed ID: 23189868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
